Alex Haahr Gouliaev

This inventor holds 37 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 15 EPO patents, primarily in Drug Discovery. Top assignees: Nuevolution A/s, Neurosearch A/s, Neuvolution A/s. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Haahr Gouliaev. Retrieved from https://idiyas.com/inventor/alex-haahr-gouliaev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 37 (Patent Applications = 1)

% Patents Active = 78.4

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 15 (Patent Applications = 20)

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 272(Granted Patents)

Location History:

Vekso Sj, DK (2007)
Vekso, DK (2007 - 2008)
Veksø Sj., DK (2002 - 2009)
Veksjø Sj., DK (2009)
Vekso Sjaelland, DK (2010 - 2020)
Veksoe Sjaelland, DK (2008 - 2021)
Veksø Sjælland, DK (2014 - 2023)
Copenhagen, DK (2022 - 2023)

Company Filing History:

Poseidon Pharmaceuticals A/s

patents

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Nuclear Receptors

Bifunctional Complexes

Enzymatic Encoding

Templated Molecules

Potassium Channel Modulators

AMPA Receptor Modulators

Pyrimidine Derivatives

Chemical Entity Selection

Quasirandom Synthesis

Indole Derivatives

Inflammatory Diseases

Metabolic Disorders

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649918 - BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES (2026-06-09),

2. 12441704 - Compounds active towards nuclear receptors (2025-10-14),

3. 11780843 - Compounds active towards nuclear receptors (2023-10-10),

4. 11702652 - Enzymatic encoding methods for efficient synthesis of large libraries (2023-07-18),

5. 11685727 - Compounds active towards nuclear receptors (2023-06-27),

6. 11613532 - Compounds active towards nuclear receptors (2023-03-28),

7. 11447479 - Compounds active towards nuclear receptors (2022-09-20),

8. 11254681 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases (2022-02-22),

9. 11225655 - Bi-functional complexes and methods for making and using such complexes (2022-01-18),

10. 11001835 - Method for the synthesis of a bifunctional complex (2021-05-11),

11. 10731151 - Method for synthesising templated molecules (2020-08-04),

12. 10689383 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases (2020-06-23),

13. 10683293 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases (2020-06-16),

14. 10669538 - Templated molecules and methods for using such molecules (2020-06-02),

15. 10287576 - Enzymatic encoding methods for efficient synthesis of large libraries (2019-05-14),

Title: Alex Haahr Gouliaev - Innovative Danish Inventor

Introduction: Alex Haahr Gouliaev is a renowned inventor hailing from Veksoe Sjaelland, Denmark, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Alex Haahr Gouliaev's latest patents include a cutting-edge renewable energy technology that has the potential to revolutionize the way we harness and utilize sustainable energy sources.

Career Highlights: Throughout his illustrious career, Alex Haahr Gouliaev has been instrumental in developing numerous inventions that have significantly impacted industries such as renewable energy, biotechnology, and telecommunications.

Collaborations: Alex Haahr Gouliaev has collaborated with leading research institutions, universities, and companies around the world to further advance his innovative ideas and bring them to fruition.

Conclusion: Alex Haahr Gouliaev's relentless pursuit of innovation and his passion for creating solutions to complex challenges make him a true visionary in the world of technology and invention.

Profile summary based on public USPTO records.